Softwr

Healthcare · head to head

Visage Imaging vs Woebot Health

Visage Imaging logo

Visage Imaging

Healthcare

Server-side streaming PACS built for radiologists reading very large studies over thin connections

From
On request
Rated
-
Full reviewWebsite
Woebot Health logo

Woebot Health

Healthcare

Conversational CBT chatbot that withdrew from consumer distribution and now sells only to payers and providers

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Visage Imaging pricing is per exam against a minimum annual volume, so an organisation whose imaging activity is flat pays a floor while a growing one sees the software line rise every year rather than amortise.; Woebot Health the company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • They diverge on capability: Visage Imaging covers Server-side rendering, Woebot Health covers Scripted CBT dialogue.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Visage Imaging and Woebot Health actually diverge.

Attributes where Visage Imaging and Woebot Health differ
AttributeVisage ImagingWoebot Health
PlatformsWindows, macOS, Web, iOS, CloudiOS, Android, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Visage Imaging

  • Server-side rendering
  • One Viewer
  • Native multi-dimensional tools
  • Digital breast tomosynthesis reading
  • Open archive
  • Cloud PACS operations
  • AI accelerator
  • On the fly patient jacket

Only in Woebot Health

  • Scripted CBT dialogue
  • Mood tracking
  • Crisis routing
  • Between-session support
  • Payer deployment
  • Provider copilot positioning
  • Research licensing
  • Population reporting

What people use each for

The jobs each tool is most often brought in to do.

Visage Imaging

  • An academic health system whose radiologists read from home and cannot tolerate a thousand slice CT taking minutes to opennot Woebot Health
  • A breast imaging service moving to tomosynthesis where study sizes have made the existing PACS unusable at volumenot Woebot Health
  • A teleradiology group covering many client sites that needs one viewer rather than a client-specific workstation per contractnot Woebot Health
  • A health system mid migration that needs priors from three legacy archives assembled into one patient jacket before the data move finishesnot Woebot Health

Woebot Health

  • A health plan wanting a low intensity behavioural health option for members on a waiting list for therapynot Visage Imaging
  • A provider organisation offering structured between-session CBT practice to patients already in treatmentnot Visage Imaging
  • A research group running a trial that needs a clinically scripted rather than generative conversational agent for safety reasonsnot Visage Imaging
  • A payer targeting a specific population such as postpartum members where scripted CBT content already existsnot Visage Imaging

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Visage Imaging

  • Pricing is per exam against a minimum annual volume, so an organisation whose imaging activity is flat pays a floor while a growing one sees the software line rise every year rather than amortise.
  • Module breadth outside radiology is narrower than at Sectra or the large modality vendors, so a group planning to digitise pathology on the same platform will not find it here.
  • Server-side rendering shifts the cost to central infrastructure, so the saving on radiologist workstations is partly offset by what you spend on servers or cloud compute.
  • Pro Medicus concentrates on very large contracts, and smaller imaging groups report long sales cycles and little appetite from the vendor for deals below a certain volume.
  • Diagnostic AI is third party, surfaced through the accelerator framework rather than developed in house, so algorithm licensing, validation and monitoring remain the buyer problem.

Woebot Health

  • The company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • It is not an FDA cleared treatment for any indication, so it cannot be positioned to members as therapy and cannot substitute for a covered behavioural health benefit.
  • The scripted, non-generative design that makes it safe also makes it feel rigid next to current conversational AI, and engagement drops off quickly once users hit the edges of the script.
  • Published evidence is short-horizon symptom change in selected populations, mostly young adults, with little evidence of durable benefit or effect at whole-population scale.
  • With consumer distribution gone, the remaining business depends on a small number of payer and provider contracts, so a buyer should assume real vendor continuity risk over a multi-year term.

Pricing, plan by plan

Visage Imaging

On request
  • Visage 7 enterprise contract$undefined/year
    • Transaction pricing per exam with a minimum annual volume commitment
    • Seven to ten year terms typical for health system contracts
    • Contract totals for major deals are disclosed by Pro Medicus to the ASX

Woebot Health

On request
  • Woebot for payers and providers$undefined/year
    • Contracted per member per month or as a population licence
    • Sold to health plans and provider organisations, not to employers or individuals
    • No consumer purchase route since the app closed in June 2025

Which should you pick?

Choose Visage Imaging if

  • You need server-side rendering.
  • You work on Windows, macOS, Web, iOS, Cloud.
  • You also want one viewer.
Visage Imaging review

Choose Woebot Health if

  • You need scripted cbt dialogue.
  • You work on iOS, Android, Web.
  • You also want mood tracking.
Woebot Health review

Questions people ask

Is Visage Imaging or Woebot Health better?
Neither clearly leads. Visage Imaging starts at On request and Woebot Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Visage Imaging or Woebot Health?
Visage Imaging starts at On request and Woebot Health at On request.
Does Visage Imaging or Woebot Health run on more platforms?
Visage Imaging runs on Windows, macOS, Web, iOS, Cloud. Woebot Health runs on iOS, Android, Web.
What is Visage Imaging best used for?
Visage Imaging is most often used for an academic health system whose radiologists read from home and cannot tolerate a thousand slice ct taking minutes to open, a breast imaging service moving to tomosynthesis where study sizes have made the existing pacs unusable at volume, a teleradiology group covering many client sites that needs one viewer rather than a client-specific workstation per contract, a health system mid migration that needs priors from three legacy archives assembled into one patient jacket before the data move finishes. Of those, an academic health system whose radiologists read from home and cannot tolerate a thousand slice ct taking minutes to open and a breast imaging service moving to tomosynthesis where study sizes have made the existing pacs unusable at volume are not what Woebot Health is typically brought in for.
What can Visage Imaging do that Woebot Health cannot?
Visage Imaging covers Server-side rendering, One Viewer, Native multi-dimensional tools, Digital breast tomosynthesis reading. Woebot Health covers Scripted CBT dialogue, Mood tracking, Crisis routing, Between-session support.

Answered from the vendors’ own pages

Visage Imaging: Who owns Visage Imaging?

Pro Medicus Limited, listed on the Australian Securities Exchange. That listing means major contract values and terms are publicly announced.

Woebot Health: Is Woebot still available?

Not to consumers. The consumer app closed in June 2025. The company continues to offer the product to payers, providers and researchers.

Visage Imaging: How is Visage priced?

Per exam, against a minimum annual volume, on multi-year terms. Because Pro Medicus discloses large contract totals and durations to the market, buyers can estimate a per exam rate before entering negotiation.

Woebot Health: Is it FDA cleared?

No. It held Breakthrough Device designation but never obtained marketing authorisation, and the founder cited the cost of that pathway as the reason for closing the consumer app.

Visage Imaging: Is Visage 7 FDA cleared for diagnostic interpretation?

Yes, Visage 7 holds 510(k) clearance for diagnostic viewing including mammography and tomosynthesis on validated displays. Confirm the exact cleared modality list for your intended use.

Woebot Health: Is it generative AI?

Historically no. The dialogue is clinician-written and rule-based, a deliberate safety choice that limits how naturally it converses.

Visage Imaging: Does it work as a full cloud PACS?

Yes, Visage 7 runs complete PACS operations in the cloud rather than cloud viewing over an on-premise archive.

Woebot Health: What does the evidence show?

Randomised studies reported reduced depressive symptoms over short periods in selected populations, notably young adults. That is symptom change in a trial, not demonstrated population outcomes.

Share

Related pages

More on Visage Imaging

More on Woebot Health

Keep looking

Other head to heads